美国阿片类药物过量导致的死亡率:CDC奇迹分析的趋势 (1999-2024)
Sophia Ahmed1, Syed Sarmad Javaid2, Aamna Nasir3
1Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
Population health management
|December 10, 2025
概括
美国的阿片类药物过量死亡人数在过去20年中急剧增加,死亡率从每10万成年人中的4.41人上升到每10万成年人中的22.84人. 持续存在的性别,种族,年龄和地区差异凸显了持续的公共卫生危机.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 美国面临严重的阿片类药物流行,过去二十年来过量服用死亡人数显著增加.
- 虽然在COVID-19大流行之前已经取得了进展,但最近与阿片类药物相关的死亡率上升,需要重新评估国家趋势.
研究的目的:
- 从1999年到2024年,分析美国25岁及以上成年人阿片类药物过量死亡率的国家趋势.
- 确定阿片类药物相关死亡的人口和区域差异,以告知有针对性的公共卫生干预措施.
主要方法:
- 使用CDC WONDER多重死亡原因数据库对阿片类药物过量死亡的回顾性分析.
- 通过ICD-10代码T40.0-T40.4和T40.6.4识别死亡情况.
- 按年,性别,年龄,种族/民族和地区计算死亡率,使用Joinpoint回归进行时间趋势分析.
主要成果:
- 总共发生了806,765例阿片类药物过量死亡,年龄调整后的死亡率 (AAMR) 从每10万人中从4.41增加到22.84.
- 男人始终表现出比女性更高的AMR. 观察到显著的种族差异,非西班牙裔美国印第安人/阿拉斯加原住民,非西班牙裔白人和非西班牙裔黑人人口的比例最高.
- 35-44岁的年龄组是死亡率最高的. 东北地区报告了最高的AAMR,其次是中西部,南部和西部.
结论:
- 在美国,阿片类药物过量仍然是一个关键的公共卫生问题.
- 持续的人口 (性别,种族,年龄) 和死亡率的区域差异强调了需要量身定制的战略.
- 有针对性的干预措施对于有效减少不同人口和地理区域的阿片类药物过量死亡率至关重要.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...


